StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
LIAN

LianMedical

LIANY Pharmaceutical Preparations EDGAR ↗
$0.05
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$5.14M
Revenue (TTM)
Net income (TTM)
-$88.0M
EPS (TTM)
$-0.81
P/E ratio
Dividend yield
Free cash flow
-$101M
Cash
$103M
Total assets
$263M
Gross margin
52-week range
$0.05 – $0.18

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Exit or disposal costs; Delisting notice or listing-rule failure; Regulation FD disclosure; Other events Feb 13, 2024 8-K Entered a material agreement; Terminated a material agreement Dec 26, 2023 8-K Director or officer change; Regulation FD disclosure Dec 20, 2023 8-K Director or officer change; Regulation FD disclosure Dec 19, 2023 8-K Regulation FD disclosure Dec 6, 2023 8-K Other events Dec 1, 2023 10-Q Quarter ended 2023-09-30 Nov 13, 2023 8-K Results of operations (earnings release) Nov 13, 2023 8-K Entered a material agreement; Terminated a material agreement; Completed an acquisition or disposition; Regulation FD disclosure Oct 30, 2023 10-Q Quarter ended 2023-06-30 Aug 14, 2023 8-K Results of operations (earnings release) Aug 14, 2023 8-K Shareholder vote results Jun 23, 2023 10-Q Quarter ended 2023-03-31 May 11, 2023 8-K Results of operations (earnings release) May 11, 2023 8-K Regulation FD disclosure May 1, 2023 8-K Regulation FD disclosure; Other events Apr 26, 2023 8-K Other events Apr 21, 2023 10-K Fiscal year ended 2022-12-31 Mar 28, 2023 8-K Results of operations (earnings release) Mar 27, 2023 8-K Director or officer change Mar 17, 2023 8-K Entered a material agreement; Regulation FD disclosure Dec 19, 2022 8-K Director or officer change Dec 13, 2022 10-Q Quarter ended 2022-09-30 Nov 10, 2022 8-K Results of operations (earnings release); Regulation FD disclosure Nov 10, 2022 8-K Other events Oct 12, 2022 10-Q Quarter ended 2022-06-30 Aug 11, 2022 8-K Results of operations (earnings release) Aug 11, 2022 8-K Shareholder vote results Jun 10, 2022 10-Q Quarter ended 2022-03-31 May 12, 2022 8-K Results of operations (earnings release); Regulation FD disclosure May 12, 2022 8-K Director or officer change Apr 8, 2022 10-K Fiscal year ended 2021-12-31 Mar 31, 2022 8-K Results of operations (earnings release) Mar 30, 2022 8-K Regulation FD disclosure Mar 2, 2022 10-Q/A Quarter ended 2021-09-30 Jan 10, 2022 10-Q Quarter ended 2021-09-30 Dec 9, 2021 8-K Results of operations (earnings release) Dec 9, 2021 8-K Entered a material agreement; Took on a direct financial obligation Nov 10, 2021 8-K Amended charter or bylaws Nov 3, 2021
Other filings
SC 13G Nov 14, 2024